An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction

American Journal of Cardiology - Tập 67 - Trang 789-796 - 1991
Joel W. Hay1,2, Ellison H. Wittels1,2, Antonio M. Gotto1,2
1From The Hoover Institution, Stanford University, Stanford, California, U.S.A.
2From the Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, U.S.A.

Tài liệu tham khảo

Stamler, 1986, Is relationship between serum cholesterol and risk of premature death from coronary disease continuous and graded?, JAMA, 256, 2823, 10.1001/jama.1986.03380200061022 Kannel, 1971, Serum cholesterol, lipoproteins, and risk of coronary heart disease: The Framingham Study, Ann Intern Med, 74, 1, 10.7326/0003-4819-74-1-1 1985, 253, 2080 National Heart, Lung, Blood Institute, 1987 Lipid Research Clinics Program, 1984, The lipid research clinics coronary primary prevention trial results: I. Reduction in the incidence of coronary heart disease, JAMA, 251, 351, 10.1001/jama.1984.03340270029025 Lipid Research Clinics Program, 1984, The lipid research clinics coronary primary prevention trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering, JAMA, 251, 365, 10.1001/jama.1984.03340270043026 Frick, 1987, Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipedemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease, N Engl J Med, 317, 1237, 10.1056/NEJM198711123172001 Oster, 1987, Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease: the case of cholestyramine, JAMA, 258, 2381, 10.1001/jama.1987.03400170067025 Weinstein, 1985, Cost-effectiveness of interventions to prevent or treat coronary heart disease, Ann Rev Public Health, 6, 41, 10.1146/annurev.pu.06.050185.000353 Berwick, 1980 Kinosian, 1988, Cutting into cholesterol: cost-effective alternatives for treating hypercholesterolemia, JAMA, 259, 2249, 10.1001/jama.1988.03720150025030 Taylor, 1987, Cholesterol reduction and life expectancy—a model incorporating multiple risk factors, Ann Intern Med, 106, 605, 10.7326/0003-4819-106-4-605 1986, Lovastatin Study Group II: therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia, JAMA, 256, 2829, 10.1001/jama.1986.03380200067023 East, 1986, Normal cholesterol levels with lovastatin (mevinolin) therapy in a child with homozygous familial hypercholesterolemia following liver transplantation, JAMA, 256, 2843, 10.1001/jama.1986.03380200081026 Weinstein, 1977, Foundations of cost-effectiveness analysis for health and medical practices, N Engl J Med, 296, 716, 10.1056/NEJM197703312961304 Shurtleff, 1974, Section 30. Some characteristics related to the incidence of cardiovascular disease and death. Framingham Study, 18-year follow-up McGee, 1977, Section 28. Probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics Abbott, 1987, Section 37. The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics McGee, 1976, Section 31: The results of the Framingham Study applied to four other U.S.-based epidemiologic studies of cardiovascular disease Cupples, 1988, Section 35: Survival following initial cardiovascular events: 30 year follow-up 1988 Tobert, 1987, New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethyl glutaryl-coenzyme A reductase, Circulation, 76, 534, 10.1161/01.CIR.76.3.534 National Center For Health Statistics, 1988, Vital Statistics of the United States, 1986, vol II National Center for Health Statistics, 1987, Vital Statistics of the United States, 1983, vol II Sorlie, 1977, Section 32. Cardiovascular disease and death following myocardial infarction and angina pectoris D'Agostino, 1989, Trends in CHD and risk factors at age 55–64 in the Framingham Study, Int J Epidemiol, 18, 567 National Center For Health Statistics, 1987, Disability days, United States, 1983 Wittels, 1990, Medical costs of coronary artery disease, Am J Cardiol, 65, 432, 10.1016/0002-9149(90)90806-C Drummond, 1987, Economic evaluation and the rational diffusion and use of health technology, Health Policy, 7, 309, 10.1016/0168-8510(87)90072-8 Centers for Disease Control, 1989, Years of potential life lost before age 65, United States, 1987, MMWR, 38, 27 National Highway Traffic Safety Administration, 1987 Partyka, 1986, Belt effectiveness in fatal accidents 1986, National Center for Health Statistics: Health: United States 1985 National Center For Health Statistics, 1986, Blood pressure levels in persons 18–74 years of age in 1976–1980, and trends in blood pressure from 1960 to 1980 in the United States Anderson, 1987, Cholesterol and mortality: 30 years of follow-up from the Framingham Study, JAMA, 257, 2176, 10.1001/jama.1987.03390160062027